Jeff Yass’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-48,800
| Closed | -$93K | – | 14419 |
|
|
2021
Q4 | $93K | Sell |
48,800
-97,200
| -67% | -$233K | ﹤0.01% | 12196 |
|
|
2021
Q3 | $439K | Buy |
146,000
+52,400
| +56% | +$187K | ﹤0.01% | 9722 |
|
|
2021
Q2 | $366K | Sell |
93,600
-343,500
| -79% | -$1.42M | ﹤0.01% | 10344 |
|
|
2021
Q1 | $2.22M | Buy |
437,100
+257,400
| +143% | +$1.34M | ﹤0.01% | 5677 |
|
|
2020
Q4 | $735K | Sell |
179,700
-31,700
| -15% | -$156K | ﹤0.01% | 7413 |
|
|
2020
Q3 | $1.03M | Buy |
211,400
+74,900
| +55% | +$409K | ﹤0.01% | 6050 |
|
|
2020
Q2 | $756K | Buy |
136,500
+51,300
| +60% | +$235K | ﹤0.01% | 6504 |
|
|
2020
Q1 | $279K | Buy |
85,200
+52,400
| +160% | +$276K | ﹤0.01% | 8117 |
|
|
2019
Q4 | $148K | Sell |
32,800
-25,100
| -43% | -$79.4K | ﹤0.01% | 8950 |
|
|
2019
Q3 | $241K | Sell |
57,900
-138,700
| -71% | -$501K | ﹤0.01% | 8736 |
|
|
2019
Q2 | $745K | Buy |
196,600
+47,100
| +32% | +$193K | ﹤0.01% | 6366 |
|
|
2019
Q1 | $626K | Buy |
+149,500
| New | +$523K | ﹤0.01% | 5874 |
|
|
2018
Q4 | – | Sell |
-10,300
| Closed | -$75K | – | 10288 |
|
|
2018
Q3 | $75K | Sell |
10,300
-9,800
| -49% | -$42.9K | ﹤0.01% | 8709 |
|
|
2018
Q2 | $74K | Sell |
20,100
-2,000
| -9% | -$9.25K | ﹤0.01% | 9162 |
|
|
2018
Q1 | $85K | Buy |
+22,100
| New | +$92.9K | ﹤0.01% | 8763 |
|
|
2017
Q4 | – | Sell |
-47,300
| Closed | -$187K | – | 10112 |
|
|
2017
Q3 | $187K | Buy |
47,300
+27,000
| +133% | +$124K | ﹤0.01% | 8067 |
|
|
2017
Q2 | $104K | Buy |
+20,300
| New | +$114K | ﹤0.01% | 8671 |
|
Jeff Yass's AGTC Position: Q4 2022 in Review
Jeff Yass sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 20,512 shares — an estimated $6K sold.
Jeff Yass first reported a position in AGTC in Q4 2016 and held it in 14 quarters. The position peaked at $797K in Q2 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Jeff Yass reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Jeff Yass sold 20,512 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $6K.
- Jeff Yass first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 14 quarters.
- Jeff Yass's Applied Genetic Technologies Corporation position peaked at $797K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.